Abstract
Background and Aims
Postoperative ileus is a transient bowel dysmotility that occurs following many types of operations and is a common complication of gastrointestinal surgery. Mosapride citrate is an agonist of the 5-hydroxytryptamine 4 receptor and accelerates upper gut motility. No study has evaluated its effect on gastrointestinal motility after surgery. The aim of this study was to investigate whether mosapride citrate reduces the duration of postoperative ileus.
Methods
Thirty patients with colon cancer who underwent colectomy were divided into two groups: the mosapride group and the control group. The mosapride group received mosapride 15 mg by mouth with a minimal amount of water three times a day, starting on postoperative day 1. The control group received only a minimal amount of water on the same schedule. Patients were allowed to resume oral feeding on postoperative day 4. Postoperative time to first flatus and defecation were evaluated, and the amount of food intake was observed. Gastrointestinal motility was recorded on postoperative day 8.
Results
The appearance ratio of interdigestive migrating contractions and the motility index at the antrum and duodenum were significantly higher in the mosapride group than in the control group. The time to first flatus and defecation were significantly shorter in the mosapride group than in the control group. The amount of food intake on postoperative days 6 and 7 was significantly larger in the mosapride group than in the control group.
Conclusion
Mosapride citrate reduces the duration of postoperative ileus and may improve outcomes after gastrointestinal surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- IMC:
-
Interdigestive migrating motor contractions
- MI:
-
Motility index
References
Yoshida N, Ito T, Karasawa T, Itoh Z. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991;257(2): 781–7.
Inui A, Yoshikawa T, Nagai R, Yoshida N, Ito T. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs. Jpn J Pharmacol 2002;90(4): 313–20.
Kadowaki M, Wang XO, Shimatani H, Yoneda S, Takaki M. 5-HT4 receptor enhances the propulsive power of the peristaltic reflex in the rat distal colon. Auton Neurosci 2002;99(1): 62–5.
Kim HS, Choi EJ, Park H. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro. Neurogastroenterol Motil 2008;20(2): 169–76.
Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N, Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther 1997;283(3): 1000–8.
Sakurai-Yamashita Y, Yamashita K, Kanematsu T, Taniyama K. Localization of the 5-HT(4) receptor in the human and the guinea pig colon. Eur J Pharmacol 1999;383(3): 281–5.
Shimatani H, Kojima Y, Kadowaki M, Nakagawa T, Fujii H, Nakajima Y, et al. A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs. Am J Physiol Gastrointest Liver Physiol 2003;285(2): G389–95.
Mochiki E, Kamiyama Y, Aihara R, Nakabayashi T, Kamimura H, Asao T, et al. Postoperative functional evaluation of jejunal interposition with or without a pouch after a total gastrectomy for gastric cancer. Am J Surg 2004;187(6): 728–35.
Haga N, Suzuki H, Shiba Y, Mochiki E, Mizumoto A, Itoh Z. Effect of TKS159, a novel 5-hydroxytryptamine4 agonist, on gastric contractile activity in conscious dogs. Neurogastroenterol Motil 1998;10(4): 295–303.
Mikami T, Ochi Y, Suzuki K, Saito T, Sugie Y, Sakakibara M. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]p yridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs. J Pharmacol Exp Ther 2008;325(1): 190–9.
Sakurai-Yamashita Y, Takada K, Takemura K, Yamashita K, Enjoji A, Kanematsu T, et al. Ability of mosapride to bind to 5-HT4 receptor in the human stomach. Jpn J Pharmacol 1999;79(4): 493–6.
Onoma M, Yogo K, Ozaki K, Kamei K, Akima M, Koga H, et al. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Clin Exp Pharmacol Physiol 2008;35(1): 35–42.
Kamiya T, Adachi H, Hirako M, Shikano M, Matsuhisa E, Wada T, et al. Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease. J Gastroenterol 2009;44(3): 183–9.
Narita K, Tsunoda A, Takenaka K, Watanabe M, Nakao K, Kusano M. Effect of mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for carcinoma. Dis Colon Rectum 2008;51(11): 1692–5.
Yamanouchi M, Shimatani H, Kadowaki M, Yoneda S, Nakagawa T, Fujii H, et al. Integrative control of rectoanal reflex in guinea pigs through lumbar colonic nerves. Am J Physiol Gastrointest Liver Physiol 2002;283(1): G148–56.
Acknowledgment
We are especially thankful to Emeritus Prof. Z Itoh, M.D. for the helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toyomasu, Y., Mochiki, E., Morita, H. et al. Mosapride Citrate Improves Postoperative Ileus of Patients with Colectomy. J Gastrointest Surg 15, 1361–1367 (2011). https://doi.org/10.1007/s11605-011-1567-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-011-1567-x